Henry Schein (NASDAQ:HSIC – Get Free Report) issued an update on its FY 2024 earnings guidance on Wednesday morning. The company provided earnings per share guidance of 4.740-4.740 for the period, compared to the consensus earnings per share estimate of 4.770. The company issued revenue guidance of $12.7 billion-$12.7 billion, compared to the consensus revenue estimate of $12.8 billion. Henry Schein also updated its Q4 2024 guidance to 1.190-1.190 EPS.
Henry Schein Stock Up 6.1 %
Shares of HSIC stock traded up $4.62 during trading hours on Wednesday, hitting $80.72. 610,562 shares of the company’s stock traded hands, compared to its average volume of 1,010,598. The company has a quick ratio of 0.82, a current ratio of 1.42 and a debt-to-equity ratio of 0.46. The stock’s fifty day simple moving average is $73.07 and its two-hundred day simple moving average is $71.21. Henry Schein has a 12-month low of $63.67 and a 12-month high of $82.63. The stock has a market cap of $10.06 billion, a price-to-earnings ratio of 33.26, a PEG ratio of 2.04 and a beta of 0.89.
Henry Schein (NASDAQ:HSIC – Get Free Report) last issued its earnings results on Tuesday, November 5th. The company reported $1.22 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.17 by $0.05. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The business had revenue of $3.17 billion during the quarter, compared to analysts’ expectations of $3.24 billion. During the same period in the previous year, the company earned $1.32 earnings per share. The business’s revenue for the quarter was up .4% compared to the same quarter last year. On average, analysts expect that Henry Schein will post 4.78 EPS for the current year.
Analysts Set New Price Targets
View Our Latest Report on Henry Schein
Insider Buying and Selling at Henry Schein
In related news, COO Michael S. Ettinger sold 12,240 shares of the company’s stock in a transaction on Monday, November 18th. The shares were sold at an average price of $75.00, for a total transaction of $918,000.00. Following the completion of the transaction, the chief operating officer now owns 87,706 shares in the company, valued at approximately $6,577,950. This represents a 12.25 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders own 1.14% of the company’s stock.
About Henry Schein
Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
Featured Articles
- Five stocks we like better than Henry Schein
- What is a buyback in stocks? A comprehensive guide for investors
- 3 Steel Stocks Soaring After Tariff Announcements
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- Top Analysts’ Picks for 2025: 3 of Morgan Stanley’s Favorites
- Stock Dividend Cuts Happen Are You Ready?
- Why Salesforce Stock Could Be at Fresh Highs by February
Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.